Skip to main content
VulnerabilityPublished Updated

CVE-2020-16200: Philips Clinical Collaboration Platform · CWE-757

Affects Philips Clinical Collaboration PlatformSource CVE Database V5

0

Not known to be exploited · CVSS 6.5 Medium.

Data as of 26 Oct 2026, 14:05 UTC

CVSS 3.1 base score
6.5Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.6% chance of exploitation in 30 days – higher than 49% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 18 Sep 2020

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
Philips Clinical Collaboration PlatformAffected
  • =0
Fixed in–

AI-suggested

To mitigate CVE-2020-16200, European healthcare organizations should take several specific steps beyond generic advice: 1) Engage with Philips to confirm the availability of patches or updates addressing this vulnerability and prioritize their deployment in clinical environments. 2) Implement strict network segmentation and access controls to limit adjacent network access to the Clinical Collaboration Platform, ensuring only authorized devices and personnel can communicate with it. 3) Monitor resource utilization metrics on the platform closely to detect abnormal consumption patterns that may indicate exploitation attempts. 4) Employ intrusion detection or prevention systems (IDS/IPS) tuned to detect unusual traffic patterns or resource exhaustion behaviors within the internal network. 5) Conduct regular security assessments and penetration tests focusing on internal network threats and lateral movement scenarios to identify and remediate weaknesses that could facilitate exploitation. 6) Develop and rehearse incident response plans that include procedures for rapid isolation and recovery of affected clinical systems to minimize downtime. 7) Educate internal IT and clinical staff about the risks of internal network threats and the importance of reporting anomalies promptly. These targeted measures will help reduce the risk of exploitation and limit the impact if an attack occurs.

Description

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not properly control the allocation and maintenance of a limited resource, thereby enabling an attacker to influence the amount of resources consumed, eventually leading to the exhaustion of available resources.

References

Community reviews

Loading reviews…